1 Min Read
Dec 12 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd
* phases ii/iii clinical trial approval granted for "yimitasvir phosphate" by china food and drug administration Source text (bit.ly/2gRidgD) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.